India’s primary market is heading into one of its busiest stretches of the year, with investors bracing for a flurry of initial public offerings (IPOs) and listings. The coming week will see four fresh public issues worth a combined ₹830 crore, alongside nearly 15 company listings, making it a crucial period for both retail and institutional participants. Leading the IPO pack is KSH International’s ₹710-crore mainboard issue, while marquee listings such as ICICI Prudential AMC and Corona Remedies are expected to dominate market conversations.
In this article, we delve into India’s action-packed IPO calendar for the coming week, unpacking the four upcoming public issues, key SME offerings, and the much-anticipated listings of ICICI Prudential AMC and Corona Remedies, along with what they signal for investor sentiment.
Credits: Business Standard
Four IPOs Worth ₹830 Crore Set to Open
At the heart of next week’s IPO calendar is KSH International, whose mainboard offering accounts for the lion’s share of the capital being raised. The overall IPO pipeline reflects steady confidence in the primary market, even as investors remain selective amid broader market volatility.
In addition to KSH International, the SME segment will also remain active, reinforcing the trend of smaller companies tapping capital markets to fund growth. Together, these offerings signal a balanced mix of large-ticket and niche plays, catering to diverse investor appetites.#
KSH International Takes Center Stage
KSH International’s ₹710-crore IPO will open for subscription on Tuesday, December 16, 2025, and close on Thursday, December 18, 2025. The issue is priced in the range of ₹365 to ₹384 per share, positioning it as the largest IPO opening during the week.
The issue is being managed by Nuvama Wealth Management, adding institutional heft to the offering. Given its size and timing, KSH International is expected to attract significant attention from both long-term investors and listing-gain seekers, potentially setting the tone for market sentiment through the week.
SME IPOs Add Momentum to the Primary Market
While mainboard issues draw headlines, the SME segment is quietly building momentum. Neptune Logitek’s ₹46.62-crore IPO will open on Monday, December 15, and close on Wednesday, December 17, marking the first IPO launch of the week.
Two additional SME public issues are scheduled to open later in the week, underscoring the sustained appetite for smaller, growth-oriented companies. The continued activity in this segment reflects improving risk appetite and growing retail participation in SME listings.
ICICI Prudential AMC Listing Steals the Spotlight
Among the upcoming listings, ICICI Prudential AMC’s market debut is the most keenly awaited. The IPO witnessed a strong start, with over 70% subscription on the first day, indicating healthy investor interest.
Adding to the excitement, the stock is currently commanding a grey market premium (GMP) of ₹304, translating to a 14% premium over the IPO price. This has raised expectations of a solid listing performance, making it a focal point for traders and long-term investors alike.
Corona Remedies and Other Listings to Watch
Apart from ICICI Prudential AMC, several other mainboard listings are expected to keep investors busy. Corona Remedies is drawing attention with a GMP of around 30%, suggesting strong listing-day enthusiasm.
Other notable names include Nephrocare, trading at a 7% GMP, and Wakefit, with a 5% premium in the grey market. Together, these listings reflect a mixed but largely positive sentiment, where fundamentals and valuation comfort are likely to dictate investor response.
Credits: NewsBytes
A Crucial Week for Market Sentiment
With four IPOs opening and up to 15 listings lined up, the coming week could serve as a key indicator of investor confidence in India’s primary markets. Strong listings could reinforce momentum heading into the year-end, while muted performances may prompt caution.
For investors, the week offers both opportunity and risk—making careful evaluation of issue fundamentals, pricing, and broader market conditions more important than ever.
